Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    AVP stimulates red blood cell production

    Author:
    HT Staff
    Publish date: December 1, 2017

    Researchers say they have uncovered a new function of arginine vasopressin (AVP). It seems this hormone does more than maintain fluid balance for...

    • Read More

    News

    Team finds no evidence that gadolinium causes neurologic harm

    Author:
    HT Staff
    Publish date: December 1, 2017

    CHICAGO—There is no evidence to suggest that accumulation of gadolinium in the brain speeds cognitive decline, according to research presented at...

    • Read More

    News

    Study reveals potential target for AML treatment

    Author:
    HT Staff
    Publish date: November 30, 2017

    New research has revealed a potential therapeutic target for acute myeloid leukemia (AML)—the methyl transferase enzyme METTL3. Researchers found...

    • Read More

    News

    Inhibitor exhibits activity against range of lymphomas

    Author:
    HT Staff
    Publish date: November 30, 2017

    Preclinical research suggests the dual PI3K/mTOR inhibitor PQR309 has activity against several types of lymphoma and works well in combination...

    • Read More

    News

    FDA grants drug orphan designation for AML, MDS

    Author:
    HT Staff
    Publish date: November 30, 2017

    The US Food and Drug Administration (FDA) has granted orphan drug designation to AMV564, a CD33/CD3 bispecific antibody, for the treatment of...

    • Read More

    News

    Group develops MM-specific CAR T-cell therapy

    Author:
    HT Staff
    Publish date: November 29, 2017

    Researchers say they have identified a multiple myeloma (MM)-specific target for chimeric antigen receptor (CAR) T-cell therapy. The team...

    • Read More

    News

    Mogamulizumab BLA receives priority review

    Author:
    HT Staff
    Publish date: November 29, 2017

    The US Food and Drug Administration (FDA) has accepted for priority review the biologics license application (BLA) for mogamulizumab....

    • Read More

    News

    FDA grants priority review to NDA for avatrombopag

    Author:
    HT Staff
    Publish date: November 29, 2017

    The US Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) for avatrombopag. Avatrombopag is a...

    • Read More

    News

    Study reveals predictor of early mortality in AML

    Author:
    HT Staff
    Publish date: November 28, 2017

    New research has shown an increased risk of early death in patients with acute myeloid leukemia (AML) who have high levels of indoleamine 2,3...

    • Read More

    News

    Thoughts, emotions linked to opioid use in SCD

    Author:
    HT Staff
    Publish date: November 28, 2017

    Results of a small study suggest that negative thoughts and emotions may increase opioid use in patients with sickle cell disease (SCD)....

    • Read More

    News

    Authors’ contributions to studies often unclear

    Author:
    HT Staff
    Publish date: November 28, 2017

    Although many scientific journals try to provide details about authors’ contributions to a publication by requiring explicit statements,...

    • Read More

    News

    Team identifies genetic differences between MM patients

    Author:
    HT Staff
    Publish date: November 27, 2017

    Researchers say they have identified significant genetic differences between African-American patients with multiple myeloma (MM) and Caucasian...

    • Read More

    News

    How CLL patients weigh treatment efficacy, safety, and cost

    Author:
    HT Staff
    Publish date: November 26, 2017

    New research suggests patients with chronic lymphocytic leukemia (CLL) are willing to trade treatment efficacy for a reduced risk of side effects...

    • Read More

    News

    Review suggests low incidence of BIA-ALCL in Canada

    Author:
    HT Staff
    Publish date: November 25, 2017

    Results of a safety review suggest there is a low incidence of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) in Canada....

    • Read More

    News

    CCSs have increased risk of hypertension

    Author:
    HT Staff
    Publish date: November 24, 2017

    A study of childhood cancer survivors (CCSs) suggests these individuals have an increased risk of developing hypertension as adults. The CCSs...

    • Read More

    Pages

    • « first
    • …
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    • 43
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery